TCL Archive New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors April 4, 1980
TCL Archive DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research March 8, 1991
TCL Archive Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals March 25, 1983
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
